The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease

Thyroid

Volumn 18, Issue 1, 2008, Pages 63-66

  Kubota, Sumihisa ^a   Takata, Kazuna ^a   Arishima, Takeshi ^a   Ohye, Hidemi ^a   Nishihara, Eijun ^a   Kudo, Takumi ^a   Ito, Mitsuru ^a   Fukata, Shuji ^a   Amino, Nobuyuki ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; DIPYRONE; IMMUNOGLOBULIN; PROPYLTHIOURACIL; THYROTROPIN; THYROTROPIN BINDING INHIBITOR; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; REMISSION; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSIENT THYROTOXICOSIS;

ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME; THYROTOXICOSIS; THYROTROPIN; THYROXINE; TIME FACTORS;

EID: 38649098825     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0164     Document Type: Article

References (15)

1. Kubota S, Tamai H, Ohye H, Fukata S, Kuma K, Miyauchi A 2004 Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J 51:213-217.
2. Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P 1988 Prediction of remission after antithyroid drug treatment in Graves' disease. Q J Med 66:175-189.
3. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR, Schernthaner G, Schatz H, Pickardt CR, Kotulla P 1989 Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120:689-701.
4. Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K 1995 A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs. Clin Endocrinol (Oxf) 43:551-556.
5. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A 1997 Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7:369-375.
6. Kashiwai T, Hidaka Y, Takano T, Tatsumi KI, Izumi Y, Shimaoka Y, Tada H, Takeoka K, Amino N 2003 Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease. Endocr J 50:45-49.
7. Papapetrou PD, Jackson IM 1975 Thyrotoxicosis due to "silent" thyroiditis. Lancet 1:361-363.
8. Gluck FB, Nusynowitz ML, Plymate S 1975 Chronic lymphocytic thyroiditis, thyrotoxicosis, and low radioactive iodine uptake. Report of four cases. N Engl J Med 293:624-628.
9. Check JH, Avellino J 1980 Painless thyroiditis and transient thyrotoxicosis after Graves' disease. JAMA 244:1361.
10. Rosen CJ, Adler RA 1992 Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75:1531-1534.
11. Diamond T, Vine J, Smart R, Butler P 1994 Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 120:8-11.
12. Wakasugi M, Wakao R, Tawata M, Gan N, Inoue M, Koizumi K, Onaya T 1994 Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry. Thyroid 4:179-182.
13. Falk RH 2001 Atrial fibrillation. N Engl J Med 344:1067-1078.
14. Yamada T, Aizawa T, Koizumi Y, Komiya I, Ichikawa K, Hashizume K 1994 Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease. J Am Geriatr Soc 42:513-516.
15. Brokken LJ, Wiersinga WM, Prummel MF 2003 Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients. J Clin Endocrinol Metab 88:4135-4138.